
An Improved Epigenetic Algorithm for Guiding Low Dose CT Lung Cancer ScreeningAward last edited on: 3/9/2025
Sponsored Program
SBIRAwarding Agency
NIH : NCITotal Award Amount
$1,870,732Award Phase
2Solicitation Topic Code
394Principal Investigator
Robert A PhilibertCompany Information
Behavioral Diagnostics Inc
15 Prospect Place
Iowa City, IA 52246
Iowa City, IA 52246
(319) 358-8602 |
N/A |
N/A |
Location: Single
Congr. District: 01
County: Johnson
Congr. District: 01
County: Johnson
Phase I
Contract Number: N/AStart Date: 8/1/2023 Completed: 7/31/2025
Phase I year
2023Phase I Amount
$1Phase II
Contract Number: 1R44CA285136-01Start Date: 8/1/2023 Completed: 7/31/2025
Phase II year
2023(last award dollars: 2024)
Phase II Amount
$1,870,731Public Health Relevance Statement:
Narrative The purpose of this application is to complete development of a DNA methylation test can help determine whether a smoker should undergo low dose CT screening for Lung Cancer and if this methylation test can help predict risk for cancer. Terms: